http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6908e24ff3528b81a55f8295eb80f87a
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Wagner |
| name | Denisa D Wagner Denisa D. Wagner |
| given-name | Denisa D. Denisa D |
| organization-name | Departments of Medicine and Anatomy and Cellular Biology, Tufts University School of Medicine, Boston, MA From the Department of Biology (V.S.D., E.V., A.Y., M.K.), Massachusetts Institute of Technology, Cambridge; and Immune Disease Institute and Department of Pathology (J.M., W.B., M.B., D.D.W.), Harvard Medical School, Boston, Mass. Current address for V.S.D.: Charles River Laboratories Inc, Wilmington, Mass. Current address for J.M.: Outcome Sciences, Cambridge, Mass. Current address for W.B.: Department of Medicine and Cardeza Foundation, Thomas Jefferson University, Philadelphia, Pa. Immune Disease Institute, Boston, MA 02115;; Program in Cellular and Molecular Medicine, Children’s Hospital Boston, Boston, MA 02115;; Department of Pathology, Harvard Medical School, Boston, MA 02115; From Immune Disease Institute Inc (J.K., A.K.C., I.S.P., D.D.W.) and the Department of Pathology (J.K., A.K.C., D.D.W.), Harvard Medical School, Boston, Mass; Department of Biology (A.Y., M.K.), Massachusetts Institute of Technology, Cambridge, Mass; Medical University of South Carolina (C.N.), Cell and Molecular Pharmacology, Charleston; and Molecular Oncology Research Institute (R.A.V.E.), Tufts–New England Medical Center, Boston, Mass. Program in Cellular and Molecular Medicine USA; Division of Hematology/OncologyBoston Children's HospitalBoston Massachusetts USA; Department of PediatricsHarvard Medical SchoolBoston Massachusetts USA From the Immune Disease Institute, Boston, MA (S.F.D.M., G.L.S., T.A.F., D.D.W.); Program in Cellular and Molecular Medicine, Children’s Hospital Boston, Boston, MA (S.F.D.M., G.L.S., T.A.F., D.D.W.); Department of Pediatrics, Harvard Medical School, Boston, MA (S.F.D.M., G.L.S., T.A.F., D.D.W.); Laboratory for Thrombosis Research, KULeuven Kulak, Kortrijk, Belgium (S.F.D.M.); and Temple Autoimmunity Center, Department of Microbiology and Immunology, Temple University School of Medicine,... The CBR Institute for Biomedical ResearchHarvard Medical School Boston MA 02115; Department of PathologyHarvard Medical School Boston MA 02115 Immune Disease Institute, Boston, MA;; Program in Cellular and Molecular Medicine, Children's Hospital Boston, MA;; Department of Pathology, Harvard Medical School, Boston, MA; and Center for Blood Research and Department of Pathology, Harvard Medical School, Boston, MA 02115; Howard Hughes Medical Institute, Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; and Department of Molecular Medicine, Max Planck Institute for Biochemistry, 82152 Martinsried, Germany The CBR Institute for Biomedical Research, Harvard Medical School, Boston, MA 02115 From The Center for Blood Research, Harvard Medical School, Boston, MA. From the Division of Hematology and Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston; Center for Blood Research and Department of Pathology, Harvard Medical School, Boston; and Departments of Medical Oncology and Cancer Biology, Dana-Farber Cancer Institute, Boston, MA. Immune Disease Institute and; Department of Pathology, Harvard Medical School, Boston, MA; Program in Cellular and Molecular Medicine Division of Hematology/Oncology Boston Children's Hospital; Department of Pediatrics Immunology Graduate Program, Division of Medical Sciences Harvard Medical School; Department of Pathology Brigham and Women's Hospital Boston Massachusetts From the CBR Institute for Biomedical Research and Department of Pathology, Harvard Medical School, Boston, Mass. Immune Disease Institute and; Department of Pathology, Harvard Medical School, Boston, MA; and Immune Disease Institute, Program in Cellular and Molecular Medicine, Children’s Hospital Boston, Boston, MA 02115, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA 02115, USA. Immune Disease Institute, Boston, MA 02115;; Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, MA 02115;; Department of Pediatrics, Harvard Medical School, Boston, MA 02115; From the Vascular Research Division, Department of Pathology, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Center for Blood Research and Department of Pathology, Harvard Medical School, Boston, MA. From the Immune Disease Institute (S.F.D.M., D.D.W.) and the Program in Cellular and Molecular Medicine (S.F.D.M., D.D.W.), Children's Hospital Boston, Boston, MA; the Department of Pediatrics (S.F.D.M., D.D.W.), Harvard Medical School, Boston, MA; the Laboratory for Thrombosis Research (S.F.D.M.), KULeuven Campus Kortrijk, Kortrijk, Belgium; and the Department of Neurology (G.S., C.K.), University of Wuerzburg, Wuerzburg, Germany. Department of Medicine, University of Rochester Medical Center, Rochester , NY 14642. Howard Hughes Medical Institute and Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Building E17, Room 227, Cambridge, MA 02139; and Center for Blood Research and Department of Pathology, Harvard Medical School, 800 Huntington Avenue, Boston, MA 02115 Immune Disease Institute,; Program in Cellular and Molecular Medicine, Children's Hospital Boston, and; Division of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA; and *Center for Blood Research, §Brigham and Women's Hospital, and ‡Department of Pathology and ‖Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115; and **Howard Hughes Medical Institute and ¶Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; *Center for Blood Research, §Brigham and Women's Hospital, and ‡Department of Pathology and ‖Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115; and **Howard Hughes Medical Institute and ¶Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 Authors' Affiliations: 1The Immune Disease Institute, 2The Program in Cellular and Molecular Medicine, Children's Hospital Boston, and 3Department of Pathology, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1The Immune Disease Institute, 2The Program in Cellular and Molecular Medicine, Children's Hospital Boston, and 3Department of Pathology, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1The Immune Disease Institute, 2The Program in Cellular and Molecular Medicine, Children's Hospital Boston, and 3Department of Pathology, Harvard Medical School, Boston, Massachusetts From the Center for Blood Research (Z.M.D., A.A.B., D.D.W.), Department of Pathology (Z.M.D., D.D.W.), Harvard Medical School, Boston, Mass. Immune Disease Institute, Boston, MA;; Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, MA;; Department of Pathology, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA; Department of Pediatrics Harvard Medical School Boston Massachusetts; Program in Cellular and Molecular Medicine Boston Children's Hospital Boston Massachusetts 1CBR Institute for Biomedical Research and; 2Department of Pathology, Harvard Medical School, Boston, MA 02115 From the CBR Institute for Biomedical Research, and the Department of Pathology, Harvard Medical School, Boston, MA From the Program in Cellular and Molecular Medicine (J.I.B., A.B., T.A.F., A.S.S., M.G., K.M., D.D.W.) and Division of Hematology/Oncology (D.D.W.), Boston Children’s Hospital, Boston, MA; Department of Pediatrics (J.I.B., A.B., T.A.F., A.S.S., D.D.W.) and Immunology Graduate Program, Division of Medical Sciences (K.M.), Harvard Medical School, Boston, MA; Laboratory for Clinical Thrombosis and Hemostasis, Department of Internal Medicine (J.I.B., H.t.C.), Department of Cardiology (I.A.J., M.O.V., H... From the Center for Blood Research and Department of Pathology, Harvard Medical School, Boston, MA. From the Departments of Pathology and Internal Medicine and the Howard Hughes Medical Institute at The University of Michigan Medical Center, Ann Arbor, MI; the Center for Cancer Research, the Department of Biology, and the Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA; and The Center for Blood Research, and the Department of Pathology, Harvard Medical School, Boston, MA. From the Department of Cardiology (J.M.S.-M.), Medical University of Vienna; Austria; Laboratory of Thrombosis and Hemostasis (Y.M., J.-F.T.), Montreal Heart Institute and Université de Montréal; Canada; Immune Disease Institute (D.D., D.D.W.), Boston, MA; Department of Pediatrics (D.D., D.D.W.), Harvard Medical School, Boston, MA; Department of Cardiology and Angiology (D.D.), University Medical Center Freiburg, Freiburg, Germany; Program in Cellular and Molecular Medicine (D.D.W.), Children's... Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA From the Schepens Eye Research Institute and Harvard Medical School (T.E.W., A.S.R.M., P.A.D.), the Immune Disease Institute (V.S.D., I.S.P., D.D.W.), and the Department of Pathology, Harvard Medical School (V.S.D., D.D.W., P.A.D.), Boston, Mass. Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, MA;; Department of Pediatrics, and; Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA The Center for Blood Research, The Harvard Medical School, Boston 02115-0001; and From the Immune Disease Institute; Program in Cellular and Molecular Medicine, Children’s Hospital Boston; and Department of Pediatrics, Harvard Medical School, Boston, MA. Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, MA 02115;; Department of Pediatrics, Harvard Medical School, Boston, MA 02115;; Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA 02115 Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, MA;; Department of Pediatrics, and; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA From the Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, United Kingdom (T.P., H.P., L.F., A.B.); Department of Cardiology, University Hospital Birmingham, United Kingdom (L.F.); Program in Cellular and Molecular Medicine (D.D.W., A.B.) and Division of Hematology/Oncology (D.D.W., A.B.), Boston Children’s Hospital, MA; and Department of Pediatrics, Harvard Medical School, Boston, MA (D.D.W., A.B.). Center for Blood Research, Department of Pathology, Harvard Medical School, Boston,2 and Program in Cellular and Molecular Medicine, Boston Children’s Hospital, MA (I.V., N.S., D.C., D.D.W.).; Department of Pediatrics, Harvard Medical School, Boston, MA (I.V., N.S., D.C., D.D.W.).; Division of Hematology/Oncology, Boston Children’s Hospital, MA (D.D.W.). Immune Disease Institute, Program in Cellular and Molecular Medicine, Children’s Hospital, Boston, and Department of Pediatrics, Harvard Medical School, Boston, MA 02115 6 From INSERM U770 (C.V.D.), Univ Paris-Sud, Le Kremlin-Bicêtre, France, and the CBR Institute for Biomedical Research and Department of Pathology (D.D.W.), Harvard Medical School, Boston Mass. From *The Center for Blood Research, the ‡Department of Pathology, and the §Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115; ‖Millenium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139; and the ¶Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; From *The Center for Blood Research, the ‡Department of Pathology, and the §Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115; ‖Millenium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139; and the ¶Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 CBR Institute for Biomedical Research, and; Department of Pathology, Harvard Medical School, Boston, MA; 1Immune Disease Institute and; 2Department of Pathology, Harvard Medical School, Boston, Massachusetts Immune Disease Institute and Department of Pathology, Harvard Medical School, Boston, MA; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, USA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts 02115, USA From the Program in Cellular and Molecular Medicine (N.S., D.C., D.D.W.), Boston Children’s Hospital, MA; Division of Hematology/Oncology (D.D.W.), Boston Children’s Hospital, MA; Department of Pediatrics, Harvard Medical School, Boston, MA (N.S., D.C., D.D.W.) From the Center for Blood Research and the Department of Pathology, Harvard Medical School, Boston, MA; the Roon Research Center for Arteriosclerosis and Thrombosis, The Scripps Research Institute, La Jolla, CA; and the Howard Hughes Medical Institute, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA. Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, MA;; Department of Pediatrics, Harvard Medical School, Boston, MA; and; Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA From The Center for Blood Research and the Department of Pathology, Harvard Medical School, Boston, MA; and the Children's Hospital Research Foundation and University of Cincinnati, OH. From the CBR Institute for Biomedical Research, Inc., and the Department of Pathology, Harvard Medical School, and the Division of Hematology/Department of Medicine, Brigham and Women's Hospital, Boston, MA; and the Rudolf Virchow Center for Experimental Biomedicine, University of Würzburg, Germany. Immune Disease Institute, Boston, MA;; Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, MA;; Department of Pediatrics, Harvard Medical School, Boston, MA; and From the Center for Blood Research and Department of Pathology, Harvard Medical School, Boston, MA; COR Therapeutics, South San Francisco, CA; and the Scripps Research Institute, La Jolla, CA. 1Immune Disease Institute and; 2Department of Pathology, Harvard Medical School, Boston, Massachusetts; and Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, MA, and Department of Pediatrics, Harvard Medical School, Boston, MA;; Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA Division of Hematology/Oncology Boston Children's Hospital Boston Massachusetts; Program in Cellular and Molecular Medicine Boston Children's Hospital Boston Massachusetts; Department of Pediatrics Harvard Medical School Boston Massachusetts CBR Institute for Biomedical Research and Department of Pathology, Harvard Medical School, Boston, MA 02115; Vascular Biology Program, Department of Surgery, Children's Hospital, Harvard Medical School, Boston, MA 02115; Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02115; Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72205; and The Scripps Research Institute,... Center for Blood Research, Institute for Biomedical Research and the Department of Pathology, Harvard Medical School, Boston, MA 02115; *CBR Institute for Biomedical Research and; Department of Pathology, Harvard Medical School, Boston, MA 02115; aThe Center for Blood Research, Department of Pathology, The Center for Blood Research, Boston, MA, USA Immune Disease Institute and Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA;; Department of Pediatrics, Harvard Medical School, Boston, MA; and Center for Blood Research and Department of Pathology, Harvard Medical School, Boston, MA 02115 1Immune Disease Institute; 2Department of Pathology, Harvard Medical School, Boston, MA 02115 From the Center for Blood Research, Departments of Pathology and Medicine, Harvard Medical School, Boston; Howard Hughes Medical Institute, Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; and Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI. From the CBR Institute for Biomedical Research (J.M., A.K.C., B.C., V.S.D., C.L.P., D.D.W.)and Department of Pathology (J.M., A.K.C., B.C., V.S.D., D.D.W.), Harvard Medical School, Boston; and Howard Hughes Medical Institute (S.A., R.O.H.), Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge. Division of Translational Medicine, Brigham and Women’s Hospital 1 , 2 , 3 , and 4 and 5; Immune Disease Institute 1 , 2 , 3 , and 4 and 5; Program in Cellular and Molecular Medicine, Children’s Hospital Boston 1 , 2 , 3 , and 4 and 5; Department of Medicine 1 , 2 , 3 , and 4 and 5; Department of Pathology, Harvard Medical School, Boston, MA 02115 1 , 2 , 3 , and 4 and 5; Division of Translational Medicine, Brigham and Women’s Hospital 1 , 2 , 3 , and 4 and 5; Immune Disease Institute 1 , 2 , 3 , and 4 and 5; Program in Cellular and Molecular Medicine, Children’s Hospital Boston 1 , 2 , 3 , and 4 and 5; Department of Medicine 1 , 2 , 3 , and 4 and 5; Department of Pathology, Harvard Medical School, Boston, MA 02115 1 , 2 , 3 , and 4 and 5; Division of Translational Medicine, Brigham and Women’s Hospital 1 , 2 , 3 , and 4 and 5; Immune Disease Institute 1 , 2 , 3 , and 4 and 5; Program in Cellular and Molecular Medicine, Children’s Hospital Boston 1 , 2 , 3 , and 4 and 5; Department of Medicine 1 , 2 , 3 , and 4 and 5; Department of Pathology, Harvard Medical School, Boston, MA 02115 1 , 2 , 3 , and 4 and 5 From The CBR Institute for Biomedical Research and Department of Pathology, Harvard Medical School, Boston, Mass. Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA. CBR Institute for Biomedical Research and; Department of Pathology, Harvard Medical School, Boston, MA Immune Disease Institute, Boston, MA;; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA;; Department of Pediatrics, Harvard Medical School, Boston, MA; Immune Disease Institute and Department of Pathology, Harvard Medical School, Boston, MA; and From the Immune Disease Institute, Boston, MA (G.L.S., A.B., S.F.D.M., J.R.V., S.M.C., D.D.W.); Program in Cellular and Molecular Medicine (G.L.S., A.B., S.F.D.M., J.R.V., S.M.C., J.E.C., D.D.W.) and Division of Hematology/Oncology (D.D.W.), Boston Children’s Hospital, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA (G.L.S., A.B., S.F.D.M., D.D.W.); and Laboratory for Thrombosis Research, KU Leuven Kulak, Kortrijk, Belgium (S.F.D.M.). Immune Disease Institute, Boston, MA;; Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, MA; and; Department of Pediatrics, Harvard Medical School, Boston, MA The Center for Hemostasis and Thrombosis Research, Division of Hematology/Oncology, New England Medical Center and Department of Anatomy and Cellular Biology, Tufts University School of Medicine, Boston, MA, USA From the Program in Cellular and Molecular Medicine (N.S., D.M.M., K.M., D.C., C.S., D.D.W.), Boston Children’s Hospital, MA; Division of Hematology/Oncology (D.D.W.), Boston Children’s Hospital, MA; Department of Pediatrics, Harvard Medical School, Boston, MA (N.S., D.M.M., K.M., D.C., D.D.W.) The Center for Blood Research and Departments of Pathology and Medicine, Harvard Medical School, Boston, MA 02115; and Howard Hughes Medical Institute and Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139 From the CBR Institute for Biomedical Research (W.B., C.L.P., G.C., V.S.D., U.H.v.A., D.D.W.) and the Department of Pathology (W.B., V.S.D., U.H.v.A., D.D.W.), Harvard Medical School, Boston, Mass; and Wyeth Research (Y.Z.), Cambridge, Mass. Immune Disease Institute, Boston, MA;; Program in Cellular and Molecular Medicine, Children's Hospital, Boston, MA;; Department of Pathology, Harvard Medical School, Boston, MA; and Children's Hospital and Harvard Medical School Boston Massachusetts From The Center for Blood Research and the Department of Pathology, Harvard Medical School, Boston, MA, and Wyeth/Genetics Institute, Cambridge, MA. From the Center for Blood Research and the Department of Pathology, Harvard Medical School, Boston, MA. Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, MA;; Department of Pediatrics, Harvard Medical School, Boston, MA;; Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA Center for Blood Research, Department of Pathology, and Brigham and Womens’ Hospital, Harvard Medical School, Boston, MA 02115 From the CBR Institute for Biomedical Research, Boston; Department of Pathology, Harvard Medical School, Boston; and Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Immune Disease Institute and Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, MA;; Department of Pediatrics, Harvard Medical School, Boston, MA; The Center for Blood Research, and Department of Pathology, Harvard Medical School, 800 Huntington Avenue, Boston, MA 02115 From the Immune Disease Institute (A.B., S.F.D.M., T.A.F., D.D.W.), Program in Cellular and Molecular Medicine, Children’s Hospital Boston (A.B., S.F.D.M., T.A.F., D.D.W.), and Department of Pediatrics (A.B., S.F.D.M., T.A.F., D.D.W.), Harvard Medical School, Boston, MA; Biology Department, Massachusetts Institute of Technology, Cambridge, MA (A.Y., J.K., M.K.); Department of Pathology and Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA ... From the CBR Institute for Biomedical Research (A.K.C., J.K., M.T.W., D.D.W.) and the Department of Pathology (A.K.C., J.K., D.D.W.), Harvard Medical School, Boston, Mass; the Centro di Riferimento Oncologico-Istituto di Ricerca e Cura a Carattere Scientifico (M.R.C., M.B., M.M., L.D.M.), National Cancer Institute, Aviano, Italy; and the International Centre for Genetic Engineering and Biotechnology (F.A.M., F.E.B., A.F.M.), Trieste, Italy. The Center for Blood Research and Departments of Pathology and Medicine, Harvard Medical School, Boston, MA 02115 Immune Disease Institute and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.; Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Hematology Division, Brigham and Women's Hospital, Boston, MA 02115, USA.; Centre de Regulacio Genomica, Parc de Recesca Biomedica de Barcelona, 08003 Barcelona, Spain. Immune Disease Institute , Boston, Massachusetts, USA; Program in Cellular and Molecular Medicine , Boston, Massachusetts, USA; Department of Pathology, Harvard Medical School , Boston, Massachusetts, USA |
Incoming Links
Showing number of triples: 1 to 265 of 265.